STAT+: Pharmalittle: CDC director overrules panel and recommends Pfizer shot for at-risk workers; DOD watchdog faults military over pharma supply chain issues
The process used by the Food and Drug Administration to vet new drugs and biologics is inconsistent in borderline cases.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our
